What is clinical quality analytics?

Clinical quality analytics is the measurement of care delivery against evidence-based standards and regulatory frameworks at the patient, provider, and panel level. The frameworks include HEDIS, MIPS, ORYX, NDNQI, NHSN, and CMS Star Ratings. It differs from generic BI because each measure has prescribed denominator, numerator, and exclusion logic — getting it wrong inflates or deflates rates against benchmarks and creates submission errors. Vizier ships with the measure logic encoded and maintained continuously.

Clinical quality analytics exists because healthcare payment, accreditation, and public reporting all depend on it. CMS quality programs — MIPS at the clinician level, IQR/OQR/VBP at the hospital level, Stars at the Medicare Advantage plan level — apply payment adjustments based on measure performance. Joint Commission accreditation requires ORYX core measure submission. NCQA Health Plan Rating and HEDIS submission affect commercial contract negotiations and Medicare Advantage bid economics. The downstream financial impact of a single measure rate moving 2 percentage points is often six or seven figures, which is why every hospital quality director, every quality improvement officer, and every health plan medical economics team spends meaningful effort on measure tracking.

The most common failure mode in clinical quality analytics is denominator and exclusion error. HEDIS Comprehensive Diabetes Care (CDC) denominator is patients 18–75 with two outpatient encounters or one inpatient stay with a diabetes diagnosis during the measurement year or year prior, continuously enrolled, with applicable exclusions (hospice, gestational diabetes O24.4x, steroid-induced E09.x). A team that runs the measure as "rows with E11.x in the diagnosis column" produces a denominator that is materially different from the NCQA-compliant denominator — and therefore a rate that's either inflated or deflated against the published benchmark. The same logic applies to MIPS measure exclusions, ORYX exclusion criteria, and NDNQI nursing-sensitive denominator definitions. Generic BI tools require customers to encode all of this logic in DAX or LookML; healthcare-native analytics platforms ship with it built in.

A useful clinical quality analytics platform does four things. First, it computes measures continuously rather than annually — so the quality director sees performance against threshold mid-year, not at submission time. Second, it surfaces denominator-eligible-but-not-numerator-met patients as an action list, not just a rate. Third, it stratifies measures by race, ethnicity, language, and other equity dimensions (now required for HEDIS, MA Stars, and HRSA UDS reporting). Fourth, it ties each measure to its financial impact — MIPS dollars, Stars quality bonus, HRSA quality bonus payments — so prioritisation is based on dollar value of intervention, not just rate gap.